Improving alcohol management in primary health care in Mexico: A return‐on‐investment analysis
Drug and Alcohol Review · 2023
DOI: 10.1111/dar.13598 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Alcohol Review, 2023. Verfasst von Adriana Solovei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Substance-Related Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme.
Abstract (Originalsprache)
Introduction
Alcohol screening, brief advice and referral to treatment (SBIRT) in primary health care is an effective strategy to decrease alcohol consumption at population level. However, there is relatively scarce evidence regarding its economic returns in non‐high‐income countries. The current paper aims to estimate the return‐on‐investment of implementing a SBIRT program in Mexican primary health‐care settings.
Methods
Empirical data was collected in a quasi‐experimental study, from 17 primary health‐care centres in Mexico City regarding alcohol screening delivered by 145 health‐care providers. This data was combined with data from a simulation study for a period of 10 years (2008 to 2017). Economic investments were calculated from a public sector health‐care perspective as clinical consultation costs (salary and material costs) and program costs (set‐up, adaptation, implementation strategies). Economic return was calculated as monetary gains in the public sector health‐care, estimated via simulated reductions in alcohol consumption, dependent on population coverage of alcohol interventions delivered to primary health‐care patients.
Results
Results showed that scaling up a SBIRT program in Mexico over a 10‐year period would lead to positive return‐on‐investment values ranging between 21% in scenario 4 (confidence interval −8.6%, 79.5%) and 110% in scenario 5 (confidence interval 51.5%, 239.8%). Moreover, over the 10‐year period, up to 16,000 alcohol‐related deaths could be avoided as a result of implementing the program. Discussion and Conclusions SBIRT implemented at national level in Mexico may lead to substantial financial gains from a public sector health‐care perspective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Promotion, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
- Department of Communication Science, Amsterdam School of Communication Research/ASCoR, University of Amsterdam, Amsterdam, The Netherlands.
- Program on Substance Abuse, Public Health Agency of Catalonia, Barcelona, Spain.
- Population Health Sciences Institute, Newcastle University, Newcastle, UK.
- ESADE, University Ramon Llull, Barcelona, Spain.
- Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.
ORCID-Profile: Adriana Solovei, Peter Anderson, Perla Medina, Jürgen Rehm, Jakob Manthey
Förderung
- Horizon 2020 Framework Programme
Zitieren
APA
Solovei, A., Rovira, P., Anderson, P., Jané-Llopis, E., Natera Rey, G., Arroyo, M., Medina, P., Mercken, L., Rehm, J., de Vries, H., & Manthey, J. (2023). Improving alcohol management in primary health care in Mexico: A return‐on‐investment analysis. Drug and Alcohol Review. https://doi.org/10.1111/dar.13598
Vancouver
Solovei A, Rovira P, Anderson P, Jané-Llopis E, Natera Rey G, Arroyo M, et al. Improving alcohol management in primary health care in Mexico: A return‐on‐investment analysis. Drug and Alcohol Review. 2023. doi:10.1111/dar.13598
BibTeX
@article{Solovei2023,
author = {Solovei, Adriana and Rovira, Pol and Anderson, Peter and Jané-Llopis, Eva and Natera Rey, Guillermina and Arroyo, Miriam and Medina, Perla and Mercken, Liesbeth and Rehm, Jürgen and de Vries, Hein and Manthey, Jakob},
title = {Improving alcohol management in primary health care in Mexico: A return‐on‐investment analysis},
journal = {Drug and Alcohol Review},
year = {2023},
doi = {10.1111/dar.13598}
}
EUVIMED